L-Carnitine Prevents Behavioural Alterations in Ketamine-Induced Schizophrenia in Mice: Possible Involvement of Oxidative Stress and Inflammation Pathways

Overview

Journal J Toxicol

Publisher Wiley

Specialty Toxicology

Date 2023 Jun 26

PMID 37363159

Authors

Mehrasa Ebrahimi

Nematollah Ahangar

Ehsan Zamani

Fatemeh Shaki

Affiliations

Soon will be listed here.

Abstract

Schizophrenia is a chronic mental complaint known as cognitive impairment. There has been evidence that inflammation and oxidative stress play a main role in schizophrenia pathophysiology. This study aimed to investigate the effects of l-carnitine, as a potent antioxidant, on the treatment of behavioural and biochemical disturbances in mice with ketamine-induced schizophrenia. In this study, schizophrenia was induced in mice by ketamine (25 mg/kg/day, ). Before induction of schizophrenia, mice were treated with l-carnitine (100, 200, and 400 mg/kg/day, ). Then, behavioural impairments were evaluated by open field (OF) assessment and social interaction test (SIT). After brain tissue isolation, reactive oxygen species (ROS), glutathione concentration (GSH), lipid peroxidation (LPO), protein carbonyl oxidation, superoxide dismutase activity (SOD), and glutathione peroxidase activity (GPx) were assessed as oxidative stress markers. Furthermore, inflammatory biomarkers such as tumour necrosis factor alpha (TNF-) and nitric oxide (NO) were evaluated in brain tissue. Our results showed ketamine increased inflammation and oxidative damage in brain tissue that was similar to behaviour disorders in mice. Interestingly, l-carnitine significantly decreased oxidative stress and inflammatory markers compared with ketamine-treated mice. In addition, l-carnitine prevented and reversed ketamine-induced alterations in the activities of SOD and GPx enzymes in mice's brains. Also, improved performance in OFT (locomotor activity test) and SIT was observed in l-carnitine-treated mice. These data provided evidence that, due to the antioxidant and anti-inflammatory effects of l-carnitine, it has a neuroprotective effect on mice model of schizophrenia.

Citing Articles

Tropisetron attenuates D-galactose-induced heart aging in male mice: activation of sirtuin1.

Mirshafa A, Shokrzadeh M, Talebpour Amiri F, Mohammadi H, Mohammadi E, Zamani E Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39704804 DOI: 10.1007/s00210-024-03711-6.

Antioxidants in neuropsychiatric disorder prevention: neuroprotection, synaptic regulation, microglia modulation, and neurotrophic effects.

Liu F, Bai Q, Tang W, Zhang S, Guo Y, Pan S Front Neurosci. 2024; 18:1505153.

PMID: 39703344 PMC: 11655488. DOI: 10.3389/fnins.2024.1505153.

References

Zhou P, Chen Z, Zhao N, Liu D, Guo Z, Tan L . Acetyl-L-carnitine attenuates homocysteine-induced Alzheimer-like histopathological and behavioral abnormalities. Rejuvenation Res. 2011; 14(6):669-79. DOI: 10.1089/rej.2011.1195. View

Sedlak J, Lindsay R . Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968; 25(1):192-205. DOI: 10.1016/0003-2697(68)90092-4. View

Takahashi T, Kinoshita M, Shono S, Habu Y, Ogura T, Seki S . The effect of ketamine anesthesia on the immune function of mice with postoperative septicemia. Anesth Analg. 2010; 111(4):1051-8. DOI: 10.1213/ANE.0b013e3181ed12fc. View

Virmani A, Binienda Z . Role of carnitine esters in brain neuropathology. Mol Aspects Med. 2004; 25(5-6):533-49. DOI: 10.1016/j.mam.2004.06.003. View

da Silva F, Cito M, da Silva M, Moura B, de Aquino Neto M, Feitosa M . Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice. Brain Res Bull. 2010; 83(1-2):9-15. DOI: 10.1016/j.brainresbull.2010.05.011. View

Connelly L, Jacobs A, Palacios-Callender M, Moncada S, Hobbs A . Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression. J Biol Chem. 2003; 278(29):26480-7. DOI: 10.1074/jbc.M302238200. View

Oliveira L, Spiazzi C, Bortolin T, Canever L, Petronilho F, Mina F . Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33(6):1003-8. DOI: 10.1016/j.pnpbp.2009.05.010. View

Marcotte E, Pearson D, Srivastava L . Animal models of schizophrenia: a critical review. J Psychiatry Neurosci. 2002; 26(5):395-410. PMC: 167198. View

Hussein A, Adel M, El-Mesery M, Abbas K, Ali A, Abulseoud O . l-Carnitine Modulates Epileptic Seizures in Pentylenetetrazole-Kindled Rats via Suppression of Apoptosis and Autophagy and Upregulation of Hsp70. Brain Sci. 2018; 8(3). PMC: 5870363. DOI: 10.3390/brainsci8030045. View

10.

Wu J, Kosten T, Zhang X . Free radicals, antioxidant defense systems, and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 46:200-6. DOI: 10.1016/j.pnpbp.2013.02.015. View

11.

Li Y, Shen R, Wen G, Ding R, Du A, Zhou J . Effects of Ketamine on Levels of Inflammatory Cytokines IL-6, IL-1β, and TNF-α in the Hippocampus of Mice Following Acute or Chronic Administration. Front Pharmacol. 2017; 8:139. PMC: 5357631. DOI: 10.3389/fphar.2017.00139. View

12.

Buyse J, Swennen Q, Niewold T, Klasing K, Janssens G, Baumgartner M . Dietary L-carnitine supplementation enhances the lipopolysaccharide-induced acute phase protein response in broiler chickens. Vet Immunol Immunopathol. 2007; 118(1-2):154-9. DOI: 10.1016/j.vetimm.2007.04.014. View

13.

Monte A, de Souza G, McIntyre R, Soczynska J, Vieira Dos Santos J, Cordeiro R . Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways. J Psychopharmacol. 2013; 27(11):1032-43. DOI: 10.1177/0269881113503506. View

14.

Kobayashi S, Iwamoto M, Kon K, Waki H, Ando S, Tanaka Y . Acetyl-L-carnitine improves aged brain function. Geriatr Gerontol Int. 2010; 10 Suppl 1:S99-106. DOI: 10.1111/j.1447-0594.2010.00595.x. View

15.

Gulcin I . Antioxidant and antiradical activities of L-carnitine. Life Sci. 2005; 78(8):803-11. DOI: 10.1016/j.lfs.2005.05.103. View

16.

Do K, Cabungcal J, Frank A, Steullet P, Cuenod M . Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol. 2009; 19(2):220-30. DOI: 10.1016/j.conb.2009.05.001. View

17.

Yadav M, Jindal D, Dhingra M, Kumar A, Parle M, Dhingra S . Protective effect of gallic acid in experimental model of ketamine-induced psychosis: possible behaviour, biochemical, neurochemical and cellular alterations. Inflammopharmacology. 2017; 26(2):413-424. DOI: 10.1007/s10787-017-0366-8. View

18.

Zugno A, Canever L, Heylmann A, Wessler P, Steckert A, Mastella G . Effect of folic acid on oxidative stress and behavioral changes in the animal model of schizophrenia induced by ketamine. J Psychiatr Res. 2016; 81:23-35. DOI: 10.1016/j.jpsychires.2016.06.013. View

19.

Vamos E, Voros K, Vecsei L, Klivenyi P . Neuroprotective effects of L-carnitine in a transgenic animal model of Huntington's disease. Biomed Pharmacother. 2009; 64(4):282-6. DOI: 10.1016/j.biopha.2009.06.020. View

20.

Flohe L, Gunzler W . Assays of glutathione peroxidase. Methods Enzymol. 1984; 105:114-21. DOI: 10.1016/s0076-6879(84)05015-1. View